---
title: "Framework for QC Analytical Testing Requirements"
ocid: "ocds-h6vhtk-0489eb"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0489eb"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0489eb.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0489eb.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "CENTRE FOR PROCESS INNOVATION LIMITED"
published: "2025-05-22"
---

# Framework for QC Analytical Testing Requirements

Buyer: CENTRE FOR PROCESS INNOVATION LIMITED  
Current stage: Award  
OCID: ocds-h6vhtk-0489eb

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0489eb)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0489eb.json)

## Summary

The Centre for Process Innovation Limited, based in Redcar, UK, has initiated a tender entitled "Framework for QC Analytical Testing Requirements" under the main category of services, specifically analysis services (CPV code: 71620000). This tender is part of an active procurement stage seeking services related to analytical testing for drug substances and products for early phase clinical trials. Notable locations include facilities in Glasgow and Darlington, with the process following an Open procedure procurement method. The tender includes various lots such as Water Testing in the Glasgow area and RNA Therapeutic/Vaccines. The tender period ends on 12 September 2024, aligning key dates for bids and awards within that timeframe. Community benefits are embedded in the contract, with potential renewals extending its duration.

This tender offers substantial opportunities for businesses in the analytical testing sector, particularly those specialising in pharmaceuticals and biotechnology. Suppliers capable of providing high-quality GMP-compliant analysis and possessing expertise in method development and process impurity testing are well-suited to compete. SMEs focusing on microbiological, chemical, and process microbial analyses, especially those with experience in RNA-LNP and recombinant protein products, could leverage this tender to expand their market presence. The open procedure encourages broad participation, allowing firms to showcase their technical specifications, turnaround times, and experience, thus fostering potential growth and collaborations.

## Notice

You are invited to submit a tender for the following requirements; analytical services for multiple modalities drug substances and drug products required for early phase clinical trials. This tender is to cover the analytical services required for release analysis of drug substance (DS) and drug product (DP).

### Lot Information

Water Testing (Glasgow Area)

The MMIC facility near Glasgow will require microbiological testing of water samples in accordance with Ph. Eur. [0169]. The following analysis techniques are required and have been included in pricing schedule for comparison: -Microbiological monitoring (Ph. Eur.) -Bacterial endotoxin testing (Ph. Eur.)

Renewal: 48 months with 1 additional 12 months period extension options at the discretion of the Authority.

RNA Therapeutic/Vaccines

Our facility in Darlington currently manufactures RNA-LNP vaccines and therapeutics for Phase 1 clinical trials. Both the drug substance and drug product are presented as liquid formulations. The requirements for RNA-LNP analysis include: - Method development, verification and Phase appropriate validation (as required) - Integrity analysis for RNA In-process samples, RNA-LNP drug substance and drug product (release and stability analysis) - Process impurity testing for RNA-LNP drug substance and drug product

Renewal: 48 months with 1 additional 12 months period extension options at the discretion of the Authority.

Recombinant Protein Therapeutics

Our facility in Darlington will, in the future, manufacture Recombinant protein vaccines and therapeutics produced in Microbial cell lines, for Phase 1 clinical trials. Both the drug substance and drug product are presented as liquid formulations. The requirements for Recombinant Protein analysis include: - Method development, verification and Phase appropriate validation (as required) - Integrity analysis for Recombinant Protein drug substance and drug product (release and stability analysis) - Process impurity testing for Recombinant Protein drug substance and drug product

Renewal: 48 months with 1 additional 12 months period extension options at the discretion of the Authority.

Process and Product Microbiology (Teesside Area)

Our facility in Darlington will require Microbiology testing to support the RNA-LNP and Recombinant Protein GMP manufacture. The following analysis is required, all under Ph.Eur: - Endotoxin (Buffers) - Endotoxin (Process product Protein) - Endotoxin (Process product RNA and RNA-LNP) - Bioburden (Buffers) - Bioburden (Process product Protein) - Bioburden (Process product RNA and RNA-LNP)

Renewal: 48 months with 1 additional 12 months period extension options at the discretion of the Authority.

Process and Product Microbiology (Glasgow Area)

Our facility in Glasgow will require Microbiology testing to support the GMP manufacturing of oligonucleotide therapies. The following analysis is required, all under Ph.Eur: - Endotoxin (Process product oligonucleotide) - Bioburden (Process product oligonucleotide)

Renewal: 48 months with 1 additional 12 months period extension options at the discretion of the Authority.

Oligonucleotides

The facility at MMIC will manufacture both single and double stranded novel oligonucleotides for early phase clinical trials. The drug substance (API) may be a lyophilised powder or solution API and the finished drug product may be a solid or liquid formulation. The requirements for oligonucleotides analysis include: - Chemical analysis for oligonucleotide drug substance and drug product (release and stability analysis) - Method development, verification and phase appropriate validation (as required)

Renewal: 48 months with 1 additional 12 months period extension options at the discretion of the Authority.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/024445-2025 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Services |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 22 May 2025 |
| Submission deadline | 12 Sep 2024 |
| Future notice date | Not specified |
| Award date | 4 Mar 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1,000,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | CENTRE FOR PROCESS INNOVATION LIMITED |
| Locality | REDCAR |
| Post town | Cleveland |
| Postcode | TS10 4RF |
| Country | England |
| ITL 1 | TLC North East (England) |
| ITL 2 | TLC3 Tees Valley |
| ITL 3 | TLC32 South Teesside |
| Local authority | Redcar and Cleveland |
| Electoral ward | Dormanstown |
| Westminster constituency | Redcar |
| Delivery location | TLM83 Inverclyde, East Renfrewshire, and Renfrewshire |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 6 |
| Supplier names | ASSURED MICRO; CATSCI; ITS TESTING SERVICES (UK) LTD TRADING AS INTERTEK P&IA; READING SCIENTIFIC SERICES; SGS; WICKHAM MICRO |

## CPV Codes

### Divisions

- 71 - Architectural, construction, engineering and inspection services

### Codes

- 71620000 - Analysis services

## Release History

- 22 May 2025 at 08:01 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/024445-2025
- 12 Aug 2024 at 13:35 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/025441-2024

## Notice URLs

- http://www.uk-cpi.com
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000774949
- https://in-tendhost.co.uk/uk-cpi/aspx/Home
- https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA30305

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0489eb. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0489eb.json.